Combination of infliximab with thiopurines significantly reduces white cell and neutrophil counts in inflammatory bowel disease patients

Conclusion Full blood counts should be closely monitored in all patients starting infliximab therapy, in particular patients receiving concomitant thiopurines.
Source: Irish Journal of Medical Science - Category: Journals (General) Source Type: research